Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to -$21.3 million.

  • Agilon Health's Free Cash Flow fell 8981.04% to -$21.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.3 million, marking a year-over-year increase of 4483.68%. This contributed to the annual value of -$71.0 million for FY2024, which is 5871.16% up from last year.
  • Latest data reveals that Agilon Health reported Free Cash Flow of -$21.3 million as of Q3 2025, which was down 8981.04% from -$38.3 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Free Cash Flow registered a high of $13.2 million during Q4 2024, and its lowest value of -$65.1 million during Q4 2023.
  • Its 5-year average for Free Cash Flow is -$33.7 million, with a median of -$35.8 million in 2025.
  • In the last 5 years, Agilon Health's Free Cash Flow tumbled by 207620.87% in 2023 and then soared by 12020.49% in 2024.
  • Over the past 5 years, Agilon Health's Free Cash Flow (Quarter) stood at -$52.3 million in 2021, then fell by 2.2% to -$53.4 million in 2022, then dropped by 21.8% to -$65.1 million in 2023, then skyrocketed by 120.2% to $13.2 million in 2024, then tumbled by 262.16% to -$21.3 million in 2025.
  • Its Free Cash Flow was -$21.3 million in Q3 2025, compared to -$38.3 million in Q2 2025 and -$35.8 million in Q1 2025.